378 related articles for article (PubMed ID: 31898218)
1. Introduction.
Sun Y
Adv Exp Med Biol; 2020; 1217():1-8. PubMed ID: 31898218
[TBL] [Abstract][Full Text] [Related]
2. Cullin-RING Ligases as attractive anti-cancer targets.
Zhao Y; Sun Y
Curr Pharm Des; 2013; 19(18):3215-25. PubMed ID: 23151137
[TBL] [Abstract][Full Text] [Related]
3. Cullin RING Ligase 5 (CRL-5): Neddylation Activation and Biological Functions.
Zhang S; Sun Y
Adv Exp Med Biol; 2020; 1217():261-283. PubMed ID: 31898233
[TBL] [Abstract][Full Text] [Related]
4. Rbx1 flexible linker facilitates cullin-RING ligase function before neddylation and after deneddylation.
Liu J; Nussinov R
Biophys J; 2010 Aug; 99(3):736-44. PubMed ID: 20682250
[TBL] [Abstract][Full Text] [Related]
5. Neddylation-CRLs regulate the functions of Treg immune cells.
Wu D; Sun Y
Bioessays; 2023 Apr; 45(4):e2200222. PubMed ID: 36709423
[TBL] [Abstract][Full Text] [Related]
6. Coupled monoubiquitylation of the co-E3 ligase DCNL1 by Ariadne-RBR E3 ubiquitin ligases promotes cullin-RING ligase complex remodeling.
Kelsall IR; Kristariyanto YA; Knebel A; Wood NT; Kulathu Y; Alpi AF
J Biol Chem; 2019 Feb; 294(8):2651-2664. PubMed ID: 30587576
[TBL] [Abstract][Full Text] [Related]
7. Determining the Effects of Neddylation on Cullin-RING Ligase-Dependent Protein Ubiquitination.
Wang K; Liu X
Curr Protoc; 2022 Mar; 2(3):e401. PubMed ID: 35316580
[TBL] [Abstract][Full Text] [Related]
8. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
Zhao Y; Morgan MA; Sun Y
Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds.
Wu K; DeVita RJ; Pan ZQ
J Biol Chem; 2024 Mar; 300(3):105752. PubMed ID: 38354780
[TBL] [Abstract][Full Text] [Related]
10. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.
Zhou H; Lu J; Yang CY; Sun Y; Wang S
Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237
[TBL] [Abstract][Full Text] [Related]
11. Targeting Protein Neddylation for Cancer Therapy.
Zhou L; Jia L
Adv Exp Med Biol; 2020; 1217():297-315. PubMed ID: 31898235
[TBL] [Abstract][Full Text] [Related]
12. Protein neddylation and its role in health and diseases.
Zhang S; Yu Q; Li Z; Zhao Y; Sun Y
Signal Transduct Target Ther; 2024 Apr; 9(1):85. PubMed ID: 38575611
[TBL] [Abstract][Full Text] [Related]
13. Neddylation-induced conformational control regulates cullin RING ligase activity in vivo.
Boh BK; Smith PG; Hagen T
J Mol Biol; 2011 Jun; 409(2):136-45. PubMed ID: 21463634
[TBL] [Abstract][Full Text] [Related]
14. [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].
Yu Q; Xiong X; Sun Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):1-19. PubMed ID: 32621419
[TBL] [Abstract][Full Text] [Related]
15. Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.
Nguyen HC; Wang W; Xiong Y
Subcell Biochem; 2017; 83():323-347. PubMed ID: 28271482
[TBL] [Abstract][Full Text] [Related]
16. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
[TBL] [Abstract][Full Text] [Related]
17. UBE2M Is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation that Promotes Targeted Degradation of UBE2F.
Zhou W; Xu J; Tan M; Li H; Li H; Wei W; Sun Y
Mol Cell; 2018 Jun; 70(6):1008-1024.e6. PubMed ID: 29932898
[TBL] [Abstract][Full Text] [Related]
18. A lysine-to-arginine mutation on NEDD8 markedly reduces the activity of cullin RING E3 ligase through the impairment of neddylation cascades.
Sui Y; Liu Y; Xu G
Biochem Biophys Res Commun; 2015 Jun; 461(4):653-8. PubMed ID: 25918018
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitination of NKCC2 by the cullin-RING E3 ubiquitin ligase family in the thick ascending limb of the loop of Henle.
Ares GR
Am J Physiol Renal Physiol; 2023 Mar; 324(3):F315-F328. PubMed ID: 36727946
[TBL] [Abstract][Full Text] [Related]
20. Targeting the neddylation pathway in cells as a potential therapeutic approach for diseases.
Ying J; Zhang M; Qiu X; Lu Y
Cancer Chemother Pharmacol; 2018 May; 81(5):797-808. PubMed ID: 29450620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
